CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock
21.59 CAD
+0.14 (+0.65%)
We assign a fundamental rating of 4 out of 10 to CHR. CHR was compared to 5 industry peers in the Passenger Airlines industry. CHR has an average financial health and profitability rating. CHR has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
In multiple years CHR reported negative net income over the last 5 years.
Each year in the past 5 years CHR had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.62%, CHR is doing worse than 60.00% of the companies in the same industry.
The Return On Equity of CHR (-6.31%) is better than 80.00% of its industry peers.
With an excellent Return On Invested Capital value of 6.40%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 3.84%.
The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -6.31% | ||
| ROIC | 6.4% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
Looking at the Operating Margin, with a value of 6.81%, CHR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR has declined.
CHR has a better Gross Margin (65.68%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.81% | ||
| PM (TTM) | N/A | ||
| GM | 65.68% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
The number of shares outstanding for CHR has been increased compared to 5 years ago.
The debt/assets ratio for CHR has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.90, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR has a Altman-Z score (0.90) which is in line with its industry peers.
The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.63, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.50, CHR is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 10.63 | ||
| Altman-Z | 0.9 |
ROIC/WACC0.79
WACC8.11%
2.3 Liquidity
CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
CHR has a Current ratio (1.22) which is comparable to the rest of the industry.
A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
CHR has a worse Quick ratio (0.63) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 92.86% over the past year.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
CHR shows a decrease in Revenue. In the last year, the revenue decreased by -8.40%.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
3.2 Future
The Earnings Per Share is expected to grow by 14.19% on average over the next years. This is quite good.
The Revenue is expected to decrease by -4.52% on average over the next years.
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.88, the valuation of CHR can be described as reasonable.
Based on the Price/Earnings ratio, CHR is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (26.60), we can say CHR is valued rather cheaply.
With a Price/Forward Earnings ratio of 10.98, the valuation of CHR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued a bit cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.23. CHR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.88 | ||
| Fwd PE | 10.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHR is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.56 | ||
| EV/EBITDA | 3.91 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHR's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3Y14.19%
5. Dividend
5.1 Amount
CHR has a Yearly Dividend Yield of 1.49%.
Compared to an average industry Dividend Yield of 0.97, CHR pays a bit more dividend than its industry peers.
CHR's Dividend Yield is slightly below the S&P500 average, which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.49% |
5.2 History
On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CHR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
TSX:CHR (1/2/2026, 7:00:00 PM)
21.59
+0.14 (+0.65%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap505.64M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78
Price Target30.26 (40.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.49% |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.88 | ||
| Fwd PE | 10.98 | ||
| P/S | 0.37 | ||
| P/FCF | 15.56 | ||
| P/OCF | 7.1 | ||
| P/B | 0.91 | ||
| P/tB | 0.93 | ||
| EV/EBITDA | 3.91 |
EPS(TTM)2.43
EY11.26%
EPS(NY)1.97
Fwd EY9.11%
FCF(TTM)1.39
FCFY6.43%
OCF(TTM)3.04
OCFY14.08%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)0.14
PEG (5Y)N/A
Graham Number35.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -6.31% | ||
| ROCE | 8.63% | ||
| ROIC | 6.4% | ||
| ROICexc | 6.56% | ||
| ROICexgc | 6.62% | ||
| OM | 6.81% | ||
| PM (TTM) | N/A | ||
| GM | 65.68% | ||
| FCFM | 2.41% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 10.63 | ||
| Debt/EBITDA | 1.32 | ||
| Cap/Depr | 32.58% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 2.74 | ||
| Cash Conversion | 33.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 0.9 |
F-Score6
WACC8.11%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.77%
EBIT Next 3Y14.37%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%
CHORUS AVIATION INC / CHR.CA FAQ
What is the fundamental rating for CHR stock?
ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.
Can you provide the valuation status for CHORUS AVIATION INC?
ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for CHORUS AVIATION INC?
CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CHR stock?
The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.88 and the Price/Book (PB) ratio is 0.91.
How financially healthy is CHORUS AVIATION INC?
The financial health rating of CHORUS AVIATION INC (CHR.CA) is 4 / 10.